Search

everythinglearnresearchcommunity

for

Search:↓

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

Testosterone is crucial for development, growth, and various body functions in mammals.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Redenyl lotion effectively promotes hair growth and improves quality of life for androgenetic alopecia patients.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Gray hair can potentially be reversed, leading to new treatments.

A new method was developed to accurately detect and measure 47 different drug ingredients in various products.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Better hair loss models needed for research.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

No cure exists for alopecia areata, and treatments are personalized.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Neurohormones help control skin health and could treat skin disorders.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Computational methods can speed up and improve the development and safety of herbal drugs.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

The document concludes that scalp health is influenced by complex factors affecting sebaceous glands, including hormones, aging, and various substances.